First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews Wu, Rongrong; Liu, Shinan; Lv, Guoli; More Wu, Rongrong; Liu, Shinan; Lv, Guoli; Deng, Chaowen; Wang, Ruolan; Zhang, Shenglin; Zhu, Dongyi; Wang, Le; Lei, Youming; Luo, Zhuang Less Anti-Cancer Drugs. 34(2):294-301, February 2023. Abstract Abstract Favorite PDF Permissions Buy SDC